Children's hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, 400014, China
NCT Number: NCT04184648
Bronchopulmonary dysplasia of premature infants is a common respiratory disease in premature infants. Long-term complications such as recurrent respiratory infection and abnormal lung function may occur in the survivors, and may increase the risk of dysplasia of the nervous system. In the past 30 years, although the monitoring and treatment technology of premature infants has been significantly improved, the incidence of BPD still shows no downward trend, and effective treatment and prevention methods for BPD are still lacking. The progress of clinical research on BPD is slow, one of the important reasons is that the definition of BPD is still not consistent, and its diagnostic and grading standards lack objectivity. To summarize the development of diagnostic criteria for BPD in the past 30 years, there are still the following disadvantages. 1. 2. In the above study, all proposed alternative BPD classification standards did not completely separate HFNC and NIV. In view of this, this study separated HFNC(High Flow Nasal Cannula Oxygen) and other NIV(Non-Invasive Ventilation) to form a new revised BPD classification standard. On this basis, a nested case-control study was conducted to compare the differences between the newly proposed classification standards and NICHD(National Institute of Child Health and Human Development) standards in 2001, Rosemary standards in 2018 and Jensen standards in predicting long-term respiratory outcomes and other systemic complications in premature infants, so as to provide a standard for more accurate diagnosis and evaluation of BPD in premature infants.
Looking for future studies?
Notify MeUp to 32 week
All sexes
Observational
Chongqing, Chongqing Municipality, 400014, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
no intervention
Time frame: up to 18 months after birth
Respiratory adverse outcomes include all types of neonatal lung diseases
Time frame: up to PMA 18-24 months
height, weight or head circumference <3rd percentile for corrected gestational age and sex, growth percentiles defined using the World Health Organization Child Growth Standards
Time frame: up to 18 months after birth
days during which the infants were given oxygen supplement
Time frame: up to 18 months after birth
including length, weight, head circumference
Time frame: up to 18 months after birth
severe neurological outcomes defined as brain retardation assessed by the Child Neurological Development Scale, developmental quotient (DQ) score <85 assessed by the Gsell developmental schedules of infants, or brain damage requiring rehabilitation treatment assessed by a qualified physical therapist;
Wang Jianhui
Other
Clinical Study on Comparative Diagnostic Criteria of Bronchopulmonary Dysplasia in Premature Infants
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01648855
Bronchopulmonary Dysplasia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Paris, France
View Trial DetailsNCT02475434
Bronchopulmonary Dysplasia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Orlando, Florida, United States
View Trial DetailsNCT06609135
Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity
Worcester, Massachusetts, United States
View Trial DetailsNCT05036603
Atelectasis Neonatal, Bronchopulmonary Dysplasia
Kahramanmaraş, Turkey (Türkiye)
View Trial Details